[在SOD-1相关的肌缩侧面硬化症中托弗森的当前景观]
Taro Ishiguro1, Tetsuya Nagata, Takanori Yokota
1Department of Neurology and Neurological Science, Institute of Science Tokyo.
Brain and nerve = Shinkei kenkyu no shinpo
|November 11, 2024
概括
托弗森是一种针对SOD1家族性肌缩侧面硬化症 (ALS) 的基因特异性疗法,现在已在美国和欧盟获得批准. 目前正在进行的评估将确定其完整的安全性和有效性.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
更多相关视频
06:49A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
Published on: October 6, 2015
19.6K
11:12Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
Published on: October 4, 2017
7.2K
